Page 3 - Daniel Vitt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

NEW YORK, April 4, 2024 /PRNewswire/ Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and.

United kingdomSan franciscoUnited statesHella kohlhofAndreas muehlerEdna kaplanPaula schwartzJessica breuDaniel vittExchange commissionImmunic incSclerosis ms researchHotel nikkoDevelopment rd dayRx communications groupMultiple sclerosis

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium

Immunic (IMUX) Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDaniel vittRobertj foxAlexandra herrmannResearch in multiple sclerosisNeurological instituteMellen centerImmunic incAmericas committee for treatmentAmericas committeeMultiple sclerosisPalm beachChief executive officerVidofludimus calciumSerum neurofilamentStaff neurologist

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanPaula schwartzJessica breuDaniel vittRobertj foxAlexandra herrmannMellen centerExchange commissionNeurological instituteResearch in multiple sclerosisAmericas committee for treatmentImmunic incAmericas committeeMultiple sclerosisPalm beach

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

EQS-News: Immunic, Inc : Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesEdna kaplanRobertj foxJessica breuAlexandra herrmannPaula schwartzDaniel vittMellen centerAmericas committee for treatmentResearch in multiple sclerosisNeurological instituteImmunic incExchange commissionDistribution servicesRx communications groupPresents data from phase

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesWest palm beachStephen gunnionDaniel vittAmericas committee for treatmentResearch in multiple sclerosisImmunic incAmericas committeeMultiple sclerosisEpstein barr virus